In the past month, the Nifty Pharma index outperformed the market by surging 7.4 per cent, as compared to 4.2 per cent rise ...
IPCA Laboratories, one of the biggest pharmaceutical companies in India, has been hit by a cybercrime and extortion group that claims to have stolen 500 gigabytes of data from its systems.
Shares of Ipca Laboratories edged lower on May 30, Tuesday, a day after the pharmaceutical company based in Mumbai reported ...
Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1800 in its research report dated June 02, 2026.
When it comes to serious quality issues at India’s Ipca Laboratories, the FDA is letting bygones be bygones in its effort to get more promising but untested treatments for COVID-19 to the market. Ipca ...
As per a share purchase agreement, Ipca will acquire 2,35,01,440 shares of Unichem from one of its promoters at a price of Rs ...
Earnings call Ipca Laboratories delivered strong Q2 FY26 results, with consolidated EBITDA margin rising to 21.68% (up 2.58pp YoY) and domestic formulation growth outpacing the Indian pharma market.
Pisgah Laboratories, an API maker, will invest $55 million to upgrade its manufacturing facility in Pisgah Forest, North Carolina, to include sterile injectables and liquid filling operations. The ...
Ipca Laboratories Ltd is quoting at Rs 1627.6, up 0.16% on the day as on 12:44 IST on the NSE. The stock is up 19.88% in last one year as compared to a 4.96% jump in NIFTY and a 15.12% jump in the ...
During market hours on Wednesday, May 29, Ipca Labs reported a 22.12 per cent year-on-year (YoY) fall in Q4FY24 consolidated net profit to ₹59.59 crore compared to a profit of ₹76.52 crore in the same ...
BENGALURU, April 24 (Reuters) - Indian pharmaceutical firm Ipca Laboratories Ltd IPCA.NS said on Monday it has agreed to buy a 33.38% stake in Unichem Laboratories Ltd UNLB.NS for up to 10.34 billion ...
Ipca Laboratories on Wednesday said it has acquired 33.38 per cent of Unichem Laboratories from one of its promoter shareholders aggregating to Rs 945.35 crore. These shares were acquired through ...